However, due to the relatively low number of HNSCC highly expressing PD-L2 (cohort 1: n=2, cohort 2: n=13), these findings need to be validated before drawing comprehensive conclusions. This evidence concerns the gene PDCD1LG2 and head and neck squamous cell carcinoma.